Financhill
Back

Gilead Sciences Quote, Financials, Valuation and Earnings

Gilead Sciences Price Quote

$90.17
-0.02 (0.46%)
(Updated: November 23, 2024 at 5:37 AM ET)

Gilead Sciences Key Stats

Sell
50
Gilead Sciences (GILD) is a Sell

Day range:
$89.27 - $90.49
52-week range:
$62.07 - $98.90
Dividend yield:
3.39%
P/E ratio:
20.04
P/S ratio:
3.99
P/B ratio:
6.08%

Volume:
4.4M
Avg. volume:
6.6M
1-year change:
19.14%
Market cap:
$112.4B
Revenue:
$27.1B
EPS:
$0.09

How Much Does Gilead Sciences Make?

Is Gilead Sciences Growing As A Company?

  • What Is Gilead Sciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.07%
  • What Is Gilead Sciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.42%

Gilead Sciences Stock Price Performance

  • Did Gilead Sciences Stock Go Up Last Month?
    Gilead Sciences share price went up by 2.3% last month
  • Did GILD's Share Price Rise Over The Last Year?
    GILD share price rose by 19.14% over the past 1 year

What Is Gilead Sciences 52-Week High & Low?

Gilead Sciences Price To Free Cash Flow

Is It Risky To Buy Gilead Sciences?

  • How Much Debt Does Gilead Sciences Have?
    Total long term debt quarterly is $23.2B
  • How Much Cash Does Gilead Sciences Have?
    Cash and short term investments quarterly total is $5B
  • What Is Gilead Sciences’s Book Value Per Share?
    Book value per share is 14.83

Is Gilead Sciences Cash Flow Positive?

  • What Is GILD Cash Flow From Operations?
    Cash flow from operations (TTM) is $10B
  • What Is Gilead Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$6.8B
  • What Is Gilead Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4B

Gilead Sciences Return On Invested Capital

  • Is Management Doing A Good Job?
    GILD return on invested capital is 0.29%
  • What Is Gilead Sciences Return On Assets?
    ROA measures how assets are converting to revenues and is 0.22%
  • What Is GILD Return On Equity?
    ROE is a measure of profitability and is 0.64%

Gilead Sciences Earnings Date & Stock Price

Gilead Sciences Competitors

  • Who Are Gilead Sciences's Competitors?
    Below is a list of companies who compete with Gilead Sciences or are related in some way:
    • Amgen Inc (AMGN)
    • Eli Lilly and Co (LLY)
    • Merck & Co Inc (MRK)
    • Pfizer Inc (PFE)
    • Vertex Pharmaceuticals Inc (VRTX)

Gilead Sciences Dividend Yield

Gilead Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: -42.2% 30.48%
Revenue: 7.02% 7.8%

Analyst Recommendations

Buy Recommendations: 14
Hold Recommendations: 14
Sell Recommendations: 0
Price Target: 96.89
Upside from Last Price: 7.43%

Major Shareholders

  • How many GILD shares are owned by institutional investors?
    1.7B GILD shares are owned by institutional investors
  • How many GILD shares are owned by insiders?
    8.4M GILD shares are owned by insiders